| PERIOD ENDING | 31-Dec-00 | | Total Revenue | 14,538 | | Cost of Revenue | 8,151 | | | Gross Profit | 6,386 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 3,426 | | Non Recurring |
-
| | Others | 962 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 1,998 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (67) | | Earnings Before Interest And Taxes | 1,931 | | Interest Expense | 156 | | Income Before Tax | 1,776 | | Income Tax Expense | 1,052 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 724 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 724 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $724 |
|
0.44% Nasdaq 
0.00 (0.05%) 
Income Statement
